We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Cardiff Oncology Inc
12 own
15 watching
Current Price
$3.45
$0.05
(1.47%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
262.7M
52-Week High
6.42000
52-Week Low
1.44000
Average Volume
1.28M
Dividend Yield
--
P/E Ratio
--
Market Capitalization262.7M52-Week High6.4200052-Week Low1.44000Average Volume1.28MDividend Yield--P/E Ratio--What does the Cardiff Oncology Inc do?
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company s TROV-053 is also in Phase II clinical trial in combination with Zytiga for metastatic castration-resistant prostate cancer. The company primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Read More
How much money does Cardiff Oncology Inc make?
News & Events about Cardiff Oncology Inc.
PR Newswire
1 year ago
Global Breast Cancer Market Size Projected To Hit $70 Billion in Revenues By 2030 Global Breast Cancer Market Size Projected To Hit $70 Billion in Revenues By 2030 PR Newswire PALM BEACH, Fla., May 5, 2023 FinancialNewsMedia.com News Commentary PALM BEACH, Fla., May 5, 2023 /PRNewswire/ -- Breast...
PR Newswire
1 year ago
Cardiff Oncology to Present at the Cowen 43rd Annual Health Care Conference Cardiff Oncology to Present at the Cowen 43rd Annual Health Care Conference PR Newswire SAN DIEGO, Feb. 27, 2023 SAN DIEGO, Feb. 27, 2023 /PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology...
PR Newswire
2years ago
Cardiff Oncology to Present at Upcoming Investor Conferences Cardiff Oncology to Present at Upcoming Investor Conferences PR Newswire SAN DIEGO, Nov. 21, 2022 SAN DIEGO, Nov. 21, 2022 /PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1...
PR Newswire
2years ago
Central Nervous System Disorders Therapeutics Market Expected to Reach $159 Billion by 2028 Central Nervous System Disorders Therapeutics Market Expected to Reach $159 Billion by 2028 PR Newswire Palm Beach, Fla., Oct. 12, 2022 FinancialNewsMedia.com News Commentary Palm Beach, Fla., Oct. 12, 2022...
PR Newswire
2years ago
Cardiff Oncology Announces New Preclinical and Clinical Data from Program in KRAS-mutated Metastatic Colorectal Cancer (mCRC) at the ESMO Congress 2022 Cardiff Oncology Announces New Preclinical and Clinical Data from Program in KRAS-mutated Metastatic Colorectal Cancer (mCRC) at the ESMO Congress...
Frequently Asked Questions
Frequently Asked Questions
What is Cardiff Oncology Inc share price today?
Can Indians buy Cardiff Oncology Inc shares?
How can I buy Cardiff Oncology Inc shares from India?
Can Fractional shares of Cardiff Oncology Inc be purchased?
What are the documents required to start investing in Cardiff Oncology Inc stocks?
What is today’s traded volume of Cardiff Oncology Inc?
What is today’s market capitalisation of Cardiff Oncology Inc?
What is the 52-Week High and Low Range of Cardiff Oncology Inc?
What percentage is Cardiff Oncology Inc down from its 52-Week High?
What percentage is Cardiff Oncology Inc up from its 52-Week Low?
Current Price
$3.45
$0.05
(1.47%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.